Oliver Hoffmann

发表

Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial.

C. Loehberg, A. Schneeweiss, J. Huober, 2024, Clinical Chemistry.

Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy.

O. Gluz, R. Kates, R. Wuerstlein, 2023, Cancer treatment reviews.